Literature DB >> 11123017

Clinical assessment and significance of inflammation in knee osteoarthritis.

V T Baddour1, J D Bradley.   

Abstract

The recognition of the role of cytokines in osteoarthritis (OA) has suggested new approaches for therapy of the disease, and also increases the importance of clinical assessment of inflammation. Accurate identification of the presence and degree of inflammation might allow the clinician to predict which individuals would respond to therapy with anti-inflammatory drugs. Several laboratory and clinical markers have been evaluated which may also serve as predictors and indicators of response to therapy and overall outcome.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 11123017     DOI： 10.1007/s11926-999-0027-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  23 in total

1.  Viability of chondroscopy as a means of cartilage assessment.

Authors:  X Ayral; M Dougados
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

2.  Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response.

Authors:  A Jones; M Doherty
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

3.  Correlation of serum concentrations of ibuprofen stereoisomers with clinical response in the treatment of hip and knee osteoarthritis.

Authors:  J D Bradley; A C Rudy; B P Katz; S I Ryan; L A Kalasinski; D C Brater; S D Hall; K D Brandt
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

4.  Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet.

Authors:  E Fex; K Eberhardt; T Saxne
Journal:  Br J Rheumatol       Date:  1997-11

5.  Chondrex: new marker of joint disease.

Authors:  S Harvey; M Weisman; J O'Dell; T Scott; M Krusemeier; J Visor; C Swindlehurst
Journal:  Clin Chem       Date:  1998-03       Impact factor: 8.327

6.  Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease.

Authors:  T D Spector; D J Hart; D Nandra; D V Doyle; N Mackillop; J R Gallimore; M B Pepys
Journal:  Arthritis Rheum       Date:  1997-04

7.  The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip.

Authors:  F Wolfe
Journal:  J Rheumatol       Date:  1997-08       Impact factor: 4.666

8.  Low dose prednisone treatment does not reduce the severity of osteoarthritis in dogs after anterior cruciate ligament transection.

Authors:  S L Myers; K D Brandt; B L O'Connor
Journal:  J Rheumatol       Date:  1991-12       Impact factor: 4.666

9.  Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders".

Authors:  J S Walker; R B Sheather-Reid; J J Carmody; J H Vial; R O Day
Journal:  Arthritis Rheum       Date:  1997-11

10.  Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis.

Authors:  T Conrozier; C Chappuis-Cellier; M Richard; P Mathieu; S Richard; E Vignon
Journal:  Rev Rhum Engl Ed       Date:  1998-12
View more
  2 in total

1.  Myostatin serum concentrations are correlated with the severity of knee osteoarthritis.

Authors:  Chang Zhao; Yan Shao; Chuangxin Lin; Chun Zeng; Hang Fang; Jianying Pan; Daozhang Cai
Journal:  J Clin Lab Anal       Date:  2016-11-23       Impact factor: 2.352

2.  The potential of multiple synovial-fluid protein-concentration analyses in the assessment of knee osteoarthritis.

Authors:  Jeffrey B Driban; Easwaran Balasubramanian; Mamta Amin; Michael R Sitler; Marvin C Ziskin; Mary F Barbe
Journal:  J Sport Rehabil       Date:  2010-11       Impact factor: 1.931
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.